Use of antioxidant supplements during breast cancer treatment: A comprehensive review

Breast Cancer Research and Treatment

Volumn 115, Issue 3, 2009, Pages 437-452

  Greenlee, Heather ^a,b   Hershman, Dawn L ^a,b,c   Jacobson, Judith S ^a,b  

^a Columbia University ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c NONE   (United States)

Author keywords

Antioxidant supplements; Breast cancer; Chemotherapy; Complementary and alternative medicine; Hormonal therapy; Radiation therapy

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOPHEROL SUCCINATE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GLUTAMINE; GLUTATHIONE; ISOFLAVONE DERIVATIVE; MELATONIN; MITOXANTRONE; MULTIVITAMIN; NIFEDIPINE; PACLITAXEL; RALOXIFENE; SELENIUM; TAMOXIFEN; UBIDECARENONE; ZINC;

ALOPECIA; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CANCER THERAPY; CARDIOTOXICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIARRHEA; DIET SUPPLEMENTATION; HOT FLUSH; HUMAN; INTESTINE MUCOSA PERMEABILITY; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; PHYTONUTRIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SIDE EFFECT; STOMATITIS; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; URINARY TRACT DISEASE; UROTOXICITY;

ANTIOXIDANTS; BREAST NEOPLASMS; DIETARY SUPPLEMENTS; HUMANS;

EID: 67349263516     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0193-0     Document Type: Review

References (59)

1. American Cancer Society (2008) Breast cancer facts & figures 2007-2008. Atlanta, American Cancer Society, Inc
2. CM Velicer CM Ulrich 2008 Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review J Clin Oncol 26 665 673
3. HS Boon F Olatunde SM Zick 2007 Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005 BMC Womens Health 7 4
4. C Buettner CH Kroenke RS Phillips 2006 Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses' health study Breast Cancer Res Treat 100 219 227 (Pubitemid 44631924)
5. JW Henderson RJ Donatelle 2004 Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer Altern Ther Health Med 10 52 57 (Pubitemid 38031560)
6. MA Navo J Phan C Vaughan 2004 An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies J Clin Oncol 22 671 677 (Pubitemid 41095070)
7. T Ashikaga K Bosompra P O'Brien 2002 Use of complimentary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians Support Care Cancer 10 542 548 (Pubitemid 36061650)
8. CA Lengacher MP Bennett KE Kip 2002 Frequency of use of complementary and alternative medicine in women with breast cancer Oncol Nurs Forum 29 1445 1452
9. RE Patterson ML Neuhouser MM Hedderson 2002 Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs J Altern Complement Med 8 477 485 (Pubitemid 34994542)
10. W Demark-Wahnefried B Peterson C McBride 2000 Current health behaviors and readiness to pursue lifestyle changes among men and women diagnosed with early stage prostate and breast carcinomas Cancer 88 674 684 (Pubitemid 30056945)
11. L VandeCreek E Rogers J Lester 1999 Use of alternative therapies among breast cancer outpatients compared with the general population Altern Ther Health Med 5 71 76
12. V Newman CL Rock S Faerber 1998 Dietary supplement use by women at risk for breast cancer recurrence. The Women's Healthy Eating and Living Study Group J Am Diet Assoc 98 285 292
13. BD Lawenda KM Kelly EJ Ladas 2008 Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst 100 773 783 10.1093/jnci/djn148
14. GM D'Andrea 2005 Use of antioxidants during chemotherapy and radiotherapy should be avoided CA Cancer J Clin 55 319 321 (Pubitemid 41377335)
15. EJ Ladas JS Jacobson DD Kennedy 2004 Antioxidants and cancer therapy: a systematic review J Clin Oncol 22 517 528 10.1200/JCO.2004.03.086
16. CM Velicer CM Ulrich 2008 Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review J Clin Oncol 26 665 673 10.1200/JCO.2007.13.5905
17. NI Weijl FJ Cleton S Osanto 1997 Free radicals and antioxidants in chemotherapy-induced toxicity Cancer Treat Rev 23 209 240 10.1016/S0305-7372(97) 90012-8
18. Hellman S (1993) Principles of radiation therapy. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 4th edn. J. B. Lippincott Co, Philadelphia
19. P Sangeetha UN Das R Koratkar 1990 Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer Free Radic Biol Med 8 15 19 10.1016/0891-5849(90)90139-A
20. KA Conklin 2000 Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects Nutr Cancer 37 1 18 10.1207/S15327914NC3701-1 (Pubitemid 30650661)
21. KA Conklin 2004 Cancer chemotherapy and antioxidants J Nutr 134 S3201 S3204
22. C Borek 2004 Dietary antioxidants and human cancer Integr Cancer Ther 3 333 341 10.1177/1534735404270578
23. CB Simone II NL Simone V Simone 2007 Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, part 2 Altern Ther Health Med 13 40 47 (Pubitemid 46427632)
24. CB Simone II NL Simone V Simone 2007 Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, part 1 Altern Ther Health Med 13 22 28 (Pubitemid 46110631)
25. D Labriola R Livingston 1999 Possible interactions between dietary antioxidants and chemotherapy Oncology (Williston Park) 13 1003 1008 (discussion 1008, 1011-1002)
26. HC Moore SJ Green JR Gralow 2007 Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer: Southwest Oncology Group/Intergroup Study 9623 J Clin Oncol 25 1677 1682 10.1200/JCO.2006.08.9383
27. JM Poulter WF White JW Dickerson 1984 Ascorbic acid supplementation and five year survival rates in women with early breast cancer Acta Vitaminol Enzymol 6 175 182 (Pubitemid 15198452)
28. M Martin-Jimenez E Diaz-Rubio JL Gonzalez Larriba 1986 Failure of high-dose tocopherol to prevent alopecia induced by doxorubicin N Engl J Med 315 894 895 (Pubitemid 16028493)
29. JE Perez M Macchiavelli BA Leone 1986 High-dose alpha-tocopherol as a preventive of doxorubicin-induced alopecia Cancer Treat Rep 70 1213 1214 (Pubitemid 16004236)
30. SA Weitzman B Lorell RW Carey 1980 Prospective study of tocopherol prophylaxis for anthracycline cardiac toxicity Curr Ther Res 28 682 686 (Pubitemid 11199478)
31. SS Legha YM Wang B Mackay 1982 Clinical and pharmacologic investigation of the effects of alpha-tocopherol on adriamycin cardiotoxicity Ann N Y Acad Sci 393 411 418 10.1111/j.1749-6632.1982.tb31279.x (Pubitemid 13206927)
32. R Lenzhofer U Ganzinger H Rameis 1983 Acute cardiac toxicity in patients after doxorubicin treatment and the effect of combined tocopherol and nifedipine pretreatment J Cancer Res Clin Oncol 106 143 147 10.1007/BF00395393 (Pubitemid 14227094)
33. DL Barton CL Loprinzi SK Quella 1998 Prospective evaluation of vitamin E for hot flashes in breast cancer survivors J Clin Oncol 16 495 500 (Pubitemid 28135591)
34. A Hoffer L Pauling 1990 Hardin Jones biostatistical analysis of mortality data for cohorts of cancer patients with a large fraction surviving at the termination of the study and a comparison of survival times of cancer patients receiving large regular oral doses of vitamin C and other nutrients with similar patients not receiving these doses J Orthomol Med 5 143 154 (Pubitemid 20284873)
35. A Hoffer L Pauling 1993 Hardin Jones biostatistical analysis of mortality data for a second set of cohorts of cancer patients with a large fraction surviving at the termination of the study and a comparison of survival times of cancer patients receiving large regular oral doses of vitamin C and other nutrients with similar patients not receiving these doses J Orthomol Med 8 157 167 (Pubitemid 23327367)
36. K Lockwood S Moesgaard T Hanioka 1994 Apparent partial remission of breast cancer in 'high risk' patients supplemented with nutritional antioxidants, essential fatty acids and coenzyme Q10 Mol Aspects Med 15 S231 S240 10.1016/0098-2997(94)90033-7
37. ML Lesperance IA Olivotto N Forde 2002 Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: an historical cohort study Breast Cancer Res Treat 76 137 143 10.1023/A:1020552501345
38. VG Premkumar S Yuvaraj K Vijayasarathy 2007 Effect of coenzyme Q10, riboflavin and niacin on serum CEA and CA 15-3 levels in breast cancer patients undergoing tamoxifen therapy Biol Pharm Bull 30 367 370 10.1248/bpb.30.367
39. AB de Souza Fede CG Bensi DC Trufelli 2007 Multivitamins do not improve radiation therapy-related fatigue: results of a double-blind randomized crossover trial Am J Clin Oncol 30 432 436 10.1097/COC.0b013e31804b40d9
40. Y Li Z Yu F Liu 2006 Oral glutamine ameliorates chemotherapy-induced changes of intestinal permeability and does not interfere with the antitumor effect of chemotherapy in patients with breast cancer: a prospective randomized trial Tumori 92 396 401 (Pubitemid 44861774)
41. DE Peterson JB Jones RG Petit II 2007 Randomized, placebo-controlled trial of Saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy Cancer 109 322 331 10.1002/cncr.22384
42. MT Nobile MG Vidili M Benasso 1989 A preliminary clinical study of cyclophosphamide with reduced glutathione as uroprotector Tumori 75 257 258 (Pubitemid 19192951)
43. P Lissoni G Tancini F Paolorossi 1999 Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: a phase II study J Pineal Res 26 169 173 10.1111/j.1600-079X.1999.tb00579.x (Pubitemid 29183120)
44. P Lissoni S Barni M Mandala 1999 Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status Eur J Cancer 35 1688 1692 10.1016/S0959-8049(99)00159-8
45. P Lissoni S Barni S Meregalli 1995 Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone Br J Cancer 71 854 856
46. SK Quella CL Loprinzi DL Barton 2000 Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial J Clin Oncol 18 1068 1074 (Pubitemid 30123785)
47. CL Van Patten IA Olivotto GK Chambers 2002 Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial J Clin Oncol 20 1449 1455 10.1200/JCO.20.6.1449
48. CA MacGregor PA Canney G Patterson 2005 A randomised double-blind controlled trial of oral soy supplements versus placebo for treatment of menopausal symptoms in patients with early breast cancer Eur J Cancer 41 708 714 10.1016/j.ejca.2005.01.005
49. KI Block AC Koch MN Mead 2008 Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials Int J Cancer 123 1227 1239 10.1002/ijc.23754
50. I Bairati F Meyer M Gelinas 2005 Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients J Clin Oncol 23 5805 5813 10.1200/JCO.2005.05.514
51. I Bairati F Meyer M Gelinas 2005 A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients J Natl Cancer Inst 97 481 488 (Pubitemid 40590429)
52. ML Kwan CB Ambrosone MM Lee 2008 The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California Cancer Causes Control 10.1007/s10552-008-9170-5
53. Greenlee H, Kwan ML, Krathwohl SE et al (2008) History of CAM use in a prospective breast cancer cohort study. In: Presented at 4th biennial cancer survivorship research conference, 18-20 June 2008, Atlanta, GA (abstr 1794)
54. Greenlee H, Gammon MD, Abrahamson PE et al (2007) Use of supplemental antioxidants after breast cancer diagnosis and during breast cancer treatment among women with breast cancer in the Long Island Breast Cancer Study Project. In: Presented at society for integrative oncology 4th international conference, 15-17 November 2007, San Francisco CA (abstr 18157)
55. D Albanes OP Heinonen JK Huttunen 1995 Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study Am J Clin Nutr 62 1427S 1430S
56. GS Omenn GE Goodman MD Thornquist 1996 Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial J Natl Cancer Inst 88 1550 1559 10.1093/jnci/88.21.1550
57. EC van Dalen HN Caron HO Dickinson 2008 Cardioprotective interventions for cancer patients receiving anthracyclines Cochrane Database Syst Rev 2 CD003917
58. DM Savarese G Savy L Vahdat 2003 Prevention of chemotherapy and radiation toxicity with glutamine Cancer Treat Rev 29 501 513 10.1016/S0305-7372(03) 00133-6
59. P Lissoni 2007 Biochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasms Pathol Biol (Paris) 55 201 204 10.1016/j.patbio.2006.12.025